Zhi Cheng

Title: Zhi Cheng: Innovator in Pharmaceutical Solutions

Introduction

Zhi Cheng is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds and compositions. With a total of 2 patents to his name, Cheng is recognized for his expertise and dedication to advancing medical science.

Latest Patents

Cheng's latest patents include a solid solution comprising (6S)-5-methyl tetrahydrofolic acid or a salt thereof. This invention discloses a composition that includes (6S)-5-methyl tetrahydrofolic acid, with a content of not less than 98.0%. The related impurity JK12A is maintained at a level not greater than 0.1%, ensuring the purity and effectiveness of the composition. Additionally, he has developed a compound known as JK12A, which is a [4-(2-amino-10-methyl-4-oxo-6,7,8,9-tetrahydro-4a,7-cycloimino-pyrimido[4,5-b][1,4]diazepine-5(4H)-yl)benzoyl]-glutamate. This compound has potential applications in drug preparation and as an active ingredient in food additives.

Career Highlights

Zhi Cheng is currently associated with Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on the research and development of pharmaceutical innovations. Cheng's contributions have been instrumental in enhancing the efficacy of medicinal compounds.

Collaborations

Cheng has collaborated with notable colleagues, including Yongzhi Cheng and Min Zhou. Their combined efforts have fostered a productive environment for innovation and research in the pharmaceutical sector.

Conclusion

Zhi Cheng's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to improving health outcomes through advanced scientific research. Cheng continues to be a valuable asset in the field of pharmaceuticals, contributing to the development of effective medical solutions.